GlassScriptPhysician profile
Amanda J Mcgee
NPI 1962492082
$6,142.08
in general payments reported to CMS, 2019-2025
41 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,256 · 2022: $1,135 · 2023: $1,359 · 2024: $1,161 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,751.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,168.52 | 2021-2025 | |
| Novo Nordisk INC | $891.09 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $585.78 | 2021-2025 | |
| Lilly USA, LLC | $561.33 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Teva Pharmaceuticals USA, INC. | $472.92 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Astrazeneca Pharmaceuticals LP | $425.17 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Biohaven Pharmaceutical Holding Company LTD. | $167.30 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $147.96 | 2021-2025 | Rexulti, Abilify Asimtufii |
| Biohaven Pharmaceuticals, INC. | $146.50 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $143.76 | 2021-2025 | |
| Nestle Healthcare Nutrition INC. | $123.86 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.76 | 2021-2023 | Trintellix |
| Astellas Pharma US INC | $101.54 | 2021-2023 | Myrbetriq |
| Glaxosmithkline, LLC. | $87.56 | 2022-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Neurocrine Biosciences, INC. | $81.27 | 2024-2025 | Ingrezza |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.